20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Sight Sciences Inc (SGHT) operates in the MEDICAL DEVICES industry and is headquartered in Menlo Park, United States with about 186 employees. Its market capitalization is roughly $513 million. In the fiscal year ended 2025-12-31, SGHT reported $77M in revenue and ($38M) in net income.
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye.
Interactive charts & full statements → Open the SGHT valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $83M | $77M | $80M | $81M | $71M | $49M | $28M | $23M | $8M |
| Gross Profit | $73M | $67M | $68M | $69M | $59M | $40M | $18M | $17M | $5M |
| Gross Margin % | 88.0% | 86.2% | 85.5% | 85.3% | 82.7% | 82.4% | 66.7% | 72.0% | 69.0% |
| Operating Income (EBIT) | ($28M) | ($37M) | ($51M) | ($57M) | ($84M) | ($51M) | ($32M) | ($24M) | ($14M) |
| Operating Margin % | -33.4% | -47.9% | -63.3% | -70.7% | -117.7% | -105.2% | -116.5% | -103.0% | -189.9% |
| Net Income | ($30M) | ($38M) | ($52M) | ($56M) | ($86M) | ($63M) | ($35M) | ($26M) | ($14M) |
| Net Margin % | -35.7% | -49.7% | -64.5% | -68.5% | -120.9% | -128.6% | -125.5% | -110.8% | -189.8% |
| EBITDA | ($26M) | ($33M) | ($46M) | ($49M) | ($80M) | ($57M) | ($32M) | ($23M) | ($14M) |
| Earnings Per Share (EPS) | $-0.56 | $-0.74 | $-1.03 | $-1.14 | $-1.80 | $-1.33 | $-0.74 | $-0.77 | $-0.44 |
| Shares Outstanding (M) | 55M | 52M | 50M | 49M | 48M | 48M | 47M | 34M | 32M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $23M | $20M | $20M | $20M | $20M | $18M | $19M | $20M |
| Gross Profit | $21M | $17M | $18M | $17M | $17M | $15M | $17M | $17M |
| Gross Margin % | 91.4% | 86.2% | 87.3% | 86.4% | 84.8% | 86.2% | 86.8% | 83.9% |
| Operating Income (EBIT) | ($4M) | ($12M) | ($4M) | ($8M) | ($12M) | ($14M) | ($12M) | ($11M) |
| Operating Margin % | -16.6% | -63.0% | -18.0% | -39.7% | -59.6% | -79.2% | -62.5% | -55.7% |
| Net Income | ($4M) | ($13M) | ($4M) | ($8M) | ($12M) | ($14M) | ($12M) | ($11M) |
| Net Margin % | -19.0% | -65.9% | -20.4% | -41.0% | -61.0% | -80.8% | -62.1% | -54.9% |
| EBITDA | ($5M) | ($12M) | ($3M) | ($7M) | ($10M) | ($13M) | ($10M) | ($10M) |
| Earnings Per Share (EPS) | $-0.08 | $-0.24 | $-0.08 | $-0.16 | $-0.23 | $-0.28 | $-0.23 | $-0.22 |
| Shares Outstanding (M) | 55M | 54M | 53M | 52M | 52M | 51M | 51M | 50M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($23M) | ($30M) | ($22M) | ($47M) | ($76M) | ($53M) | ($32M) | ($25M) | ($14M) |
| Capital Expenditures (CapEx) | $0M | $0M | $0M | $1M | $1M | $1M | $1M | $1M | $1M |
| Free Cash Flow (FCF) | ($24M) | ($30M) | ($23M) | ($48M) | ($77M) | ($53M) | ($33M) | ($26M) | ($15M) |
| FCF Margin % | -28.4% | -38.7% | -28.5% | -59.2% | -107.9% | -109.0% | -119.8% | -109.9% | -199.8% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($6M) | ($7M) | ($2M) | ($9M) | ($8M) | ($12M) | ($3M) | $1M |
| Capital Expenditures (CapEx) | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M |
| Free Cash Flow (FCF) | ($6M) | ($7M) | ($2M) | ($9M) | ($8M) | ($12M) | ($4M) | $1M |
| FCF Margin % | -24.3% | -36.0% | -9.7% | -44.6% | -39.6% | -66.3% | -18.9% | 2.7% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $105M | $115M | $143M | $167M | $213M | $280M | $73M | $31M | $8M |
| Cash & Cash Equivalents | $80M | $92M | $120M | $138M | $185M | $261M | $62M | $21M | $4M |
| Total Liabilities | $52M | $51M | $55M | $46M | $53M | $48M | $162M | $85M | $37M |
| Total Debt (Short + Long-Term) | $41M | $41M | $40M | $34M | $34M | $33M | $32M | $13M | $0M |
| Total Shareholders' Equity | $53M | $64M | $88M | $120M | $160M | $232M | ($89M) | ($55M) | ($29M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SGHT viewer.
About TickerBase · Data methodology & sources · Privacy · Terms